Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin for SIRS Prevention in Cardiac Surgery
NCT00773110Phase 2Terminated
- Sponsor
- Imperial College London
- Start
- Dec 2008
- Primary completion
- May 2011
- Countries
- 1
01
Overview
Phase 2, randomised trial of albumin (human) in Systemic Inflammatory Response Syndrome (SIRS) (2 arms), sponsored by Imperial College London. Primary endpoint: Time from surgery to intensive care unit discharge. Started Dec 2008; status: terminated.
02
Drugs
albumin (human)
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT00773110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773110.